Kestra Medical closes $148.4M public offering of 6.9M shares at $23.00

KESTRA MEDICAL TECHNOLOGIES, LTD.

Offered 6,900,000 common shares at $23.00 per share, including full exercise of underwriters' over-allotment option of 900,000 shares.
Net proceeds of approximately $148.4 million after underwriting discounts and estimated offering expenses.
Proceeds to support sales/marketing, commercialization, R&D, clinical studies, and working capital.
Underwriters included BofA Securities, Piper Sandler, J.P. Morgan, and Goldman Sachs; offering closed December 4, 2025.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.